Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00617552 · ClinicalTrials.gov registry record · Phase 2

Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery

A Phase 2 study, sponsored by Tranzyme.

Completed
Registry status
Phase 2
Development phase
267
Enrollment target

NCT00617552: Completed Phase 2 study, sponsored by Tranzyme.

NCT00617552 is a Phase 2 study that has completed, run by Tranzyme. The registered enrollment target is 267 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (101% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00617552, a Phase 2 study, has completed, sponsored by Tranzyme.

COMPLETED
Registry status
Phase 2
Development phase
267 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether TZP-101 is effective in the management of post operative ileus in subjects undergoing major open abdominal surgery (i.e. partial large bowel resection).

Interventions

  • DRUG 5% dextrose in water
  • DRUG TZP-101

Trial Details

FieldValue
Enrollment Target 267 participants
Start Date 2007-07
Est. Completion 2008-08
Phase Phase 2
Tranzyme

8 total trials

What the finished NCT00617552 record still lists

NCT00617552 is an interventional study that assigns participants to a tested intervention. The registered 267 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (101% higher).

The record links to 0 conditions, and to 2 interventions - of which 5% dextrose in water is the first listed.

NCT00617552 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00617552 about?

NCT00617552 is a clinical study titled "Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery". The purpose of this study is to determine whether TZP-101 is effective in the management of post operative ileus in subjects undergoing major open abdominal surgery (i.e. partial large bowel resection).

What is the current status of trial NCT00617552?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 267 participants. The study started on 2007-07. Estimated completion is 2008-08.

What interventions are being tested in trial NCT00617552?

The interventions under investigation include: 5% dextrose in water (DRUG), TZP-101 (DRUG).

Who is sponsoring clinical trial NCT00617552?

This trial is sponsored by Tranzyme, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00617552's enrollment target sits among peer trials

267 209th of 2000 higher than 1,792 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04997109 · 267 participants · NA

    Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

  • NCT05355701 · 267 participants · Phase 1

    A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

  • NCT06203509 · 267 participants · NA

    Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness

  • NCT05000632 · 268 participants · NA

    Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00617552, the US trial registry maintained by the National Library of Medicine. NCT00617552 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.